Live Breaking News & Updates on First Lockbody

Stay updated with breaking news from First lockbody. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Centessa Pharmaceuticals plc Announcements | Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of LB101, First LockBody® Candidate, for Solid Tumors

Investegate announcements from Centessa Pharmaceuticals plc, Centessa Pharmaceuticals Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of LB101, First LockBody® Candidate, for Solid Tumors ....

United States , City Of , United Kingdom , Kristenk Sheppard , Exchange Commission , Centessa Pharmaceuticals Announces , Drug Administration , Centessa Pharmaceuticals , Clinical Trial , First Lockbody , Investigational New Drug , Saurabh Saha , Chief Executive Officer , Annual Report , Quarterly Reports , Investegate Announcements , Investegate Company Announcements , Centessa Pharmaceuticals Plc , Lobenewswire And Globenewswire ,